ArticleParasites & vectors2025
Collaborative engagement with vector control stakeholders is key to enhance the utility of vector-borne disease models.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Climate Change and Emerging Arboviral Threats in Saudi Arabia: Epidemiology, Vector Ecology, and One Health Preparedness.Infectious disease reports · 2026Review
- A warming welcome? Belgium's increasing suitability for Aedes albopictus.Parasites & vectors · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDespite the growing complexity, computational power, and mapping capacity incorporated into vector-borne disease models, they still do not fully elucidate the role of environmental, demographic, socioeconomic, or other drivers, and rarely directly inform vector control efforts. To understand how we can improve the utility of vector-borne disease models for vector control activities, we interviewed vector control agents from the United States (USA) and the European Union.
methodsBetween July and December 2023, in-depth interviews were held using a geographically targeted convenience sample with 26 individuals from organizations involved in vector control operations: 12 in the USA and 14 in the EU. We used both deductive and inductive coding of transcribed interviews to identify themes with the goal of understanding barriers to model use and uptake.
resultsDespite the recognition that models could be useful, few interviewees reported that models informed surveillance and control activities, citing a mismatch in spatial and temporal scale between model outputs and operational decisions or a general lack of accessibility. Interviewees reported relying on experienced field experts and legacy protocols. Despite these critiques, there is belief that models can support operational decision-making.
conclusionsThe disconnect between models and users can be improved by allowing time and resources to build collaborative relationships, by acknowledging the knowledge all members bring, and by ensuring clear communication and mutual respect. Modelers must shift their focus by aligning vector-borne disease models with operational needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.